Trials / Completed
CompletedNCT03044301
Performance Thresholds Evaluation by Wet Injection Quantification and Magnetic Resonance Imaging (MRI) of Subcutaneous and Intramuscular Injections (0,65ml) of Several Configurations of Needle-free Devices (ZENEO®)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 97 (actual)
- Sponsor
- Crossject · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to evaluate the performance of the ZENEO needle free device in subcutaneous functioning limits (low performance limit and high performance limit) and for intramuscular injections.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | Intramuscular ZENEO® injection | Sodium Chloride (0.9 %) |
| COMBINATION_PRODUCT | Subcutaneous high ZENEO® injection | Sodium Chloride (0.9 %) |
| COMBINATION_PRODUCT | Subcutaneous low ZENEO® injection | Sodium Chloride (0.9 %) |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2016-06-01
- Completion
- 2016-06-01
- First posted
- 2017-02-07
- Last updated
- 2017-02-07
Source: ClinicalTrials.gov record NCT03044301. Inclusion in this directory is not an endorsement.